The present invention relates to an externally applied
drug for the treatment of
lumbar, cervical and bone joint diseases, which is characterized in that the present invention is prepared by the pharmaceutical raw materials with the following mix ratio by weight: 25 to 35 parts of Szechuan lovage
rhizome, 20 to 30 parts of Chinese angelica, 35 to 45 parts of peach seed, 20 to 30 parts of safflower, 15 to 25 parts of sappan wood, 15 to 25 parts of
cape jasmine fruit, 15 to 25 parts of nutgrass galingale
rhizome, 15 to 25 parts of
pangolin scales, 30 to 40 parts of leech, 1 to 3 parts of musk, 25 to 35 parts of dragon's blood, 20 to 30 parts of
frankincense, 20 to 30 parts of
myrrh, 15 to 25 parts of trogopterus dung, 15 to 25 parts of incised notopterygium
rhizome, 15 to 25 parts of doubleteeth pubescent angilica root, 20 to 30 parts of pedate pinallia jackinthepulpit rhizome, 25 to 35 parts of
scorpion, 15 to 25 parts of manchurian wildginger, 30 to 40 parts of dahurian
angelica root, 25 to 35 parts of divaricate
saposhnikovia root, 15 to 25 parts of
great burdock achene, 20 to 30 parts of dried ginger, 25 to 35 parts of kusnezoff
monkshood root, 25 to 35 parts of common monkshood mother root, 15 to 25 parts of pine nodular
branch, 15 to 25 parts of siberian cocklour fruit, 20 to 30 parts of snake slough, 20 to 30 parts of tall
gastrodia tuber, 30 to 40 parts of
realgar, 35 to 45 parts of common floweringquince fruit, 15 to 25 parts of seaweed, 15 to 25 parts of
kelp, 20 to 30 parts of
lilac daphne flower
bud, 20 to 30 parts of Peking
euphorbia root, 25 to 35 parts of cochinchina
momordica seed, 25 to 35 parts of
Gleditsia sinensis stings, 25 to 35 parts of
ephedra herb, 55 to 65 parts of hydrargyri oxydum rubrum, 10 to 20 parts of
borax and 10 to 20 parts of
borneol.